99mTc-HYNIC-folate: A novel receptor-based targeted radiopharmaceutical for tumor imaging

Journal of Nuclear Medicine

Volumn 40, Issue 9, 1999, Pages 1563-1569

  Guo, Wenjin ^a   Hinkle, George H ^a   Lee, Robert J ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

99mTc; Folate receptor; Tumor imaging

Indexed keywords

FOLIC ACID DERIVATIVE; RADIOPHARMACEUTICAL AGENT; RECEPTOR; TECHNETIUM DERIVATIVE; CARRIER PROTEIN; CELL SURFACE RECEPTOR; DIAGNOSTIC AGENT; FOLATE BINDING PROTEIN; FOLATE-BINDING PROTEIN; FOLIC ACID; TECHNETIUM COMPLEX; TECHNETIUM TC 99M HYNIC FOLATE; TECHNETIUM TC 99M-HYNIC-FOLATE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG RECEPTOR BINDING; DRUG SELECTIVITY; DRUG SYNTHESIS; DRUG UPTAKE; FEMALE; HUMAN; HUMAN CELL; IMAGING; INTRAVENOUS DRUG ADMINISTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; TISSUE DISTRIBUTION; TUMOR LOCALIZATION; ANIMAL; C57BL MOUSE; CANCER TRANSPLANTATION; CARCINOMA; CELL CULTURE; CELL STRAIN KB; METABOLISM; SARCOMA; SCINTISCANNING; SYNTHESIS; XENOGRAFT;

ANIMALS; CARCINOMA; CARRIER PROTEINS; FEMALE; FOLIC ACID; HUMANS; KB CELLS; MICE; MICE, INBRED C57BL; NEOPLASM TRANSPLANTATION; ORGANOTECHNETIUM COMPOUNDS; RECEPTORS, CELL SURFACE; SARCOMA, EXPERIMENTAL; TISSUE DISTRIBUTION; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED;

EID: 0032588840     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Garin-Chesa P, Campbell I, Saigo PE, et al. Trophoblast and ovarian cancer antigen LK26. Sensitivity and specificity in immunopathology and molecular identification as a folate-binding protein. Am J Pathol. 1993;142:557-567.
2. Campbell IG, Jones TA, Foulkes WD, et al. Folate-binding protein is a marker for ovarian cancer. Cancer Res. 1991;51:5329-5338.
3. Mantovani LT, Miotti S, Menard S, et al. Folate binding protein distribution in normal tissues and biological fluids from ovarian carcinoma patients as detected by the monoclonal antibodies MOv18 and MOv19. Eur J Cancer. 1994;30A:363-369.
4. Ross JF, Chaudhuri PK, Ratnam M. Differential regulation of folate receptor isoforms in normal and malignant tissues in vivo and in established cell lines. Cancer. 1994;73:2432-2443.
5. Rothberg KG, Ying YS, Kolhouse JF, et al. The glycophospholipid-linked folate receptor internalizes folate without entering the clathrin-coated pit edocytic pathway. J Cell Biol. 1990;110:637-649.
6. Weitman SD, Lark RH, Coney LR, et al. Distribution of the folate receptor GP38 in normal and malignant cell lines and tissues. Cancer Res. 1992;52:3396-3401.
7. Weitman SD, Weinberg AG, Coney LR, et al. Cellular localization of the folate receptor: potential role in drug toxicity and folate homeostasis. Cancer Res. 1992;52:6708-6711.
8. Weitman SD, Frazier KM, Kamen BA. The folate receptor in central nervous system malignancies of childhood. J Neurooncol. 1994;21:107-112.
9. Wang X, Shen F, Freisheim JH, et al. Differential stereospecifities and affinities of folate receptor isoforms for folate compounds and antifolates. Biochem Pharmacol 1992;44:1898-1901.
10. Antony AC. The biological chemistry of folate receptors. Blood. 1992;79:2807-2820.
11. Anderson RGW, Kamen BA, Rothberg KG, et al. Potocytosis: sequestration and transport of small molecules by caveolea. Science. 1992;255:410-411.
12. Kamen BA, Wang MT, Streckfuss AJ, et al. Delivery of folates to the cytoplasm of MA104 cells is mediated by a surface receptor that recycles. J Biol Chem. 1988;263:13602-13609.
13. Kamen BA, Smith AK, Anderson RG. The folate receptor works in tandem with a probenecid-sensintive carrier in MA104 cells in vitro. J Clin Invest. 1991;87:1442-1449.
14. Coney LR, Tomassetti A, Carayannopoulos L, et al. Cloning of a tumor-associated antigen: MOv18 and MOv19 antibodies recognize a folate-binding protein. Cancer Res. 1991;51:6125-6132.
15. Molthoff C, Buist M, Kenemans P, et al. Experimental and clinical analysis of the characteristics of a chimeric monoclonal antibody, MOv18, reactive with an ovarian cancer-associated antigen. J Nucl Med. 1992;33:2000.
16. Crippa F, Bolis G, Seregni E, et al. Single-dose intraperitoneal radioimmunotherapy with the murine monoclonal antibody 1-131 MOv18: clinical results in patients with minimal residual disease of ovarian cancer. Eur J Cancer. 1995;31A:686-690.
17. Crippa F, Buraggi G, Di Re M, et al Radioimmunoscintigraphy of ovarian cancer with the MOv18 monoclonal antibody. Eur J Cancer. 1991;27:724-729.
18. Ladino CA, Chari RVJ, Bourrel LA, et al. Folate-maytansinoids: target-selective drugs of low molecular weight. Int J Cancer. 1997;73:859-864.
19. Leamon CP, Low PS. Delivery of macromolecules into living cells: a method that exploits folate receptor endocytosis. Proc Natl Acad Sci USA. 1991;88:5572-5576.
20. Leamon CP, Low PS. Cytotoxicity of momordin-folate conjugates in cultured human cells. J Biol Chem. 1992;267:24966-24971,
21. Leamon CP, Low PS. Membrane folate-binding proteins are responsible for folate-protein conjugate endocytosis into cultured cells. Biochem J. 1993;291:855-860.
22. Leamon CP, Pastan I, Low PS. Cytotoxicity of folate-Pseudonomas exotoxin conjugates towards tumor cells. Contribution of translocation domain. J Biol Chem. 1993;25:24847-24854.
23. Lee RJ, Low PS. Delivery of liposomes into cultured KB cells via folate receptor-mediated endocytosis. J Biol Chem. 1994;269:3198-3204.
24. Lee RJ, Low PS. Folate-mediated tumor cell targeting of liposome-entrapped doxorubicin in vitro. Biochim Biophys Acta. 1994;1233:134-144.
25. Lee R, Wang S, Low P. Measurement of endosomal pH following folate receptor-mediated endocytosis. Biochim Biophys Acta. 1996;1312:237-242.
26. Mathias CJ, Wang S, Lee RJ, et al. Tumor-selective radiopharmaceutical targeting via receptor-mediated endocytosis of gallium-67-deferoxamine-folate. J Nucl Med. 1996;37:1003-1008.
27. Mathias CJ, Wang S, Waters DJ, et al. Indium-111-DTPA-folate as a potential folate-receptor-targeted radiopharmaceutical. J Nucl Med. 1998;39:1579-1585.
28. Mathias CJ, Hubers D, Trump DP, et al. Synthesis of Tc-99m-DTPA-folate and preliminary evaluation as a folate-receptor-targeted radiopharmaceutical [abstract]. J Nucl Med. 1997;38(suppl):87P.
29. Mathias CJ, Waters DJ, Wang S, et al. Indium-111 labeled Indium(III)-DTPA-folate as a radiopharmaceutical for targeting tumor-associated folate receptors: the effect of tumor size on targeting selectivity and radiochemical analysis of excreted tracer [abstract], 12th International Symposium on Radiopharmaceutical Chemistry. Uppsala, Sweden, 1997.
30. Wang S, Lee RJ, Cauchon G, et al. Delivery of antisense oligodeoxynucleotides against the human epidermal growth factor receptor into cultured KB cells with liposomes conjugated to folate via polyethylene glycol, Proc Natl Acad Sci USA. 1995;92:3318-3322.
31. Wang S, Lee RJ, Mathias CJ, et al. Synthesis, purification, and tumor cell uptake of gallium-67-deferoxamine-folate, a potential radiopharmaceutical for tumor imaging. Bioconj Chem. 1996;7:56-62.
32. Wang S, Luo J, Lantrip DA, et al. Design and synthesis of 111In-DTPA-folate for use as a tumor-targeted radiopharmaceutical. Bioconj Chem. 1997;8:673-679.
33. 1]-octreotide and preoperative detection of endocrine tumors. Cancer Res. 1995;55:5794S-5800S.
34. Olsen J, Pozderac R, Hinkle G, et al. Somatostatin receptor imaging of neuroendocrine tumors with indium-111 pentetreotide (Octreoscan). Semin Nucl Med. 1995;25:251-261.
35. 99mTc. Bioconj Chem. 1997;8:146-154.
36. Casalini P, Luison E, Menard S, et al. Tumor pretargeting: role of avidin/ streptavidin on monoclonal antibody internalization. J Nucl Med 1997;38:1378-1381.